Plate 50 Strategy for in vivo electroporation A, Electroporation to the scleral (RPE) side of the retina. B, Electroporation to the vitreal side of the retina. (See figure 51.1.)
Plate 51 Electrodes and procedure for in vivo electroporation. Tweezer-type electrodes (A) are placed to hold the head of newborn (P0) rat or mouse (B). (See figure 51.2.)
Plate 52 Whole-mount preparation of rat retina in vivo electroporated at P0 with CAG-GFP (Matsuda and Cepko, 2004), a GFP expression vector driven by the CAG (chicken β-actin promoter
with cytomegalovirus enhancer) promoter and harvested at P21. Images are from the scleral side. Bright-field (A), GFP (B), and merged (C ) images are shown. (See figure 51.3.)
Plate 55 A, Microchamber for in vitro electroporation. B, Orientation of the retina in the chamber. Maximum transduction efficiency can be obtained when the scleral side is facing the minus electrode. (See figure 51.7.)
Plate 56 In vitro electroporated retinal explant (whole mount). Mouse retinas of P0 CD1 (A and B), adult CD1 (C and D), or adult Swiss Webster mice with a retinal degeneration mutation (E and F) were in vitro electroporated with CAG-GFP from the scleral side (A, C, and E) or from the vitreal side (B, D, and F) and cultured for
5 days. Images A, C, and E are from the scleral side and images B, D, and F are from the vitreal side. Note that only the scleral side of developing retina or of degenerated retina is highly transfectable. In E, most of the GFP-positive cells are Müller glial cells. (See figure 51.8.)